Ground Fluor Pharmaceuticals Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Investors
-
1
Ground Fluor Pharmaceuticals General Information
Description
Developer of medical imaging products designed to focus on fluorine synthesis for positron emitting tomography imaging. The company's proprietary chemical technologies develop a synthesis of pharmaceutical compounds, such as Fluorine F-18 Agents, and develop and provide imaging agents for positron emission tomography scans, thereby enabling clients to produce fluorine in much higher yields, with much higher potency.
Contact Information
Website
www.gfpharma.comCorporate Office
- 2124 Y Street
- Flat 101
- Lincoln, NE 68503
- United States
Corporate Office
- 2124 Y Street
- Flat 101
- Lincoln, NE 68503
- United States
Ground Fluor Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 09-Jun-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 17-Apr-2014 | Completed | Startup | |||
| 3. Grant | 03-Apr-2014 | Completed | Startup | |||
| 2. Grant | 14-Jun-2012 | $150K | Completed | Startup | ||
| 1. University Spin-Out | 01-Jan-2012 | Completed | Startup |
Ground Fluor Pharmaceuticals Patents
Ground Fluor Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2014152431-A1 | Stabilization of radioiodinated and astatinated pharmaceutials and imaging agents | Inactive | 15-Mar-2013 | ||
| US-20140275539-A1 | Stabilization of radioiodinated and astatinated pharmaceuticals and imaging agents | Inactive | 15-Mar-2013 | ||
| AU-2013334166-A1 | Processes and reagents for making diaryliodonium salts | Inactive | 27-Oct-2012 | ||
| CA-2889575-A1 | Processes and reagents for making diaryliodonium salts | Inactive | 27-Oct-2012 | ||
| EP-2912011-A1 | Processes and reagents for making diaryliodonium salts | Inactive | 27-Oct-2012 | C07D475/04 |
Ground Fluor Pharmaceuticals Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cedarville Investments | Venture Capital | Minority | ||
| US National Science Foundation | Accelerator/Incubator |
Ground Fluor Pharmaceuticals FAQs
-
When was Ground Fluor Pharmaceuticals founded?
Ground Fluor Pharmaceuticals was founded in 2012.
-
Where is Ground Fluor Pharmaceuticals headquartered?
Ground Fluor Pharmaceuticals is headquartered in Lincoln, NE.
-
What industry is Ground Fluor Pharmaceuticals in?
Ground Fluor Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Ground Fluor Pharmaceuticals a private or public company?
Ground Fluor Pharmaceuticals is a Private company.
-
What is Ground Fluor Pharmaceuticals’s current revenue?
The current revenue for Ground Fluor Pharmaceuticals is .
-
Who are Ground Fluor Pharmaceuticals’s investors?
Cedarville Investments and US National Science Foundation have invested in Ground Fluor Pharmaceuticals.
-
When was Ground Fluor Pharmaceuticals acquired?
Ground Fluor Pharmaceuticals was acquired on 09-Jun-2016.
-
Who acquired Ground Fluor Pharmaceuticals?
Ground Fluor Pharmaceuticals was acquired by FluoroPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process